-- 
Baccarat, Endesa, Neurones, Valeo, Vinci: Europe Equity Preview

-- B y   N i k o l a j   G a m m e l t o f t
-- 
2011-09-22T04:00:01Z

-- http://www.bloomberg.com/news/2011-09-21/baccarat-endesa-neurones-valeo-vinci-europe-equity-preview.html
Shares of the following companies
may have unusual moves in European trading. Stock symbols are in
parentheses.  The Stoxx Europe 600 Index fell 1.7 percent to 225.33. The
Stoxx 50 Index lost 1.8 percent to 2,117.63. The Euro Stoxx 50
Index, a benchmark measure for nations using the euro, slipped 2
percent to 2,098.49.  Baccarat (BCRA)  SA: The crystal manufacturer said its
swung to a first-half net profit of 900,000 euros from a 611,000
euro year-ago loss. The shares rose 0.1 percent to 140.0 euros.  BioAlliance Pharma SA (BIO)  : The cancer drug developer
said it had a first-half loss of 8.75 million euros, compared
with net income of 10.58 million euros a year earlier. The
shares fell 1.8 percent to 3.36 euros.  Endesa SA (ELE)  : The electricity company had its long-
term credit rating raised to A- from BBB+ by  Standard & Poorâ€™s .
The shares fell 0.9 percent to 17.13 euros.  Neurones (NRO)  SA: The computer services company said
first-half operating profit rose to 12.6 million euros from 10
million euros. The shares rose 0.4 percent to 7.28 euros.  Valeo SA (FR)  : The car parts maker said it bought back
558,302 shares at average price of 33.14 euros to cover bonuses
and stock options plans. The shares fell 5 percent to 34.44
euros.  Vinci SA (DG)  : The construction company said it and
Dutch builder Royal BAM Groep NV have finalized the financing
for updating a section of the Berlin to Munich highway, a 220
million euro project. The shares fell 1.1 percent to 32.79
euros.  To contact the reporter on this story:
Nikolaj Gammeltoft in New York at 
 ngammeltoft@bloomberg.net   To contact the editor responsible for this story:
Nick Baker at   nbaker7@bloomberg.net  